Bessemer Group’s MacroGenics MGNX Stock Holding History

Bessemer Group’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-40,599	Closed	-$849K	–	1526
2014 Q3	$849K	Hold	40,599	–	–	﹤0.01%	490
2014 Q2	$882K	Buy	+40,599	New	+$853K	0.01%	469

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

Bessemer Group's MGNX Position: Q4 2014 in Review

Bessemer Group sold out of MacroGenics (MGNX) in Q4 2014, closing a stake of 40,599 shares — an estimated $849K sold.

Bessemer Group first reported a position in MGNX in Q2 2014 and held it in 2 quarters. The position peaked at $882K in Q2 2014. 107 funds tracked by Wall St. Rank hold MGNX as of Q4 2014.

Bessemer Group reported no remaining MacroGenics position as of Q4 2014 after selling out during the quarter.
Bessemer Group sold 40,599 MacroGenics shares in Q4 2014, an estimated $849K.
Bessemer Group first reported a position in MacroGenics in Q2 2014 and held it in 2 quarters.
Bessemer Group's MacroGenics position peaked at $882K in Q2 2014.
107 funds tracked by Wall St. Rank held MacroGenics as of Q4 2014.

Based on Bessemer Group's 13F filing for Q4 2014, filed 17 Feb 2015.